We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
WSE:NVO
​
​
logo

Novo Nordisk A/S (NVO)

WSE • NVO • DK0062498333

159.54Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 2,327.7 days to cover, cost to borrow 1.56%. Sign up for live short interest data.

Market Cap

180b USD | # 29 in PL

Volume

238 shares | 9.55k USD

Shares Outstanding

3.33b

Free Float Shares

94.64% | 3.16b

NYSE:NVO|
OTCPK:NONO.F|
DB:NOV|
DB:NOV0|
DB:NOV1|
DB:NOVA|
XTRA:NOV|
LSE:0QIU|
LSE:0TDD|
TSX:NOVO|
BOVESPA:N1VO34|
BASE:NVO|
BASE:NVOD|
WBAG:NNO2|
CPSE:NOVO B|
SET:NOVOB80|
NEOE:NVON

News

NVO key data

Novo Nordisk A/S (WSE: NVO) has a market capitalization of $179.56B. Last close PLN 159.54 (as of 2026-11-12); 52-week range PLN 129.26 to PLN 230.00. ORTEX data as of 2026-10-28: short interest was 0.02% of free float, 2,327.7 days to cover and the average cost to borrow was 1.56%. Sign up for live short interest data.

  • NVO news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.